FDA committee endorses plan to simplify COVID-19 vaccines

An FDA advisory committee voted unanimously Thursday in favor of a plan to streamline and simplify COVID-19 vaccine compositions in the United States by replacing initial, primary doses with the bivalent vaccines currently used as boosters.
The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 21-0 to recommend “harmonizing” the strains in COVID-19 vaccines so that all vaccines — including those used in primary series — target both the original SARS-CoV-2 strain and the omicron subvariants BA.4 and BA.5.
“There’s so much

An FDA advisory committee voted unanimously Thursday in favor of a plan to streamline and simplify COVID-19 vaccine compositions in the United States by replacing initial, primary doses with the bivalent vaccines currently used as boosters.
The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 21-0 to recommend “harmonizing” the strains in COVID-19 vaccines so that all vaccines — including those used in primary series — target both the original SARS-CoV-2 strain and the omicron subvariants BA.4 and BA.5.
“There’s so much